
How Is an IVF Treatment Plan Chosen and Why Does It Differ Between Patients?

Manar Hegazy

Majd Eddin Khaled
Two patients can begin IVF at a similar time and receive very different medication doses, monitoring schedules, fertilization methods, and embryo-transfer strategies.
This does not mean that one treatment plan is stronger or better.
IVF is not one universal protocol.
The plan is built from the patient's reproductive history, ovarian reserve, sperm findings, previous treatment response, uterine factors, and treatment goals. It is then adjusted as new information becomes available during the cycle.
Fertiliv helps patients organize medical records, testing, and previous IVF information so the treatment strategy can be reviewed and understood before therapy begins.
What Information Is Used to Build an IVF Plan?
Before medication starts, the medical team may review:
Female age
Duration of infertility
Ovarian reserve
Menstrual history
Antral follicle count
Semen analysis
Uterine and tubal findings
Previous pregnancies and miscarriages
Previous IVF or ICSI cycles
Surgical history
Chronic medical conditions
Current medication
Relevant inherited conditions
These findings help shape the stimulation strategy, fertilization approach, monitoring, and embryo-transfer plan.
Read also: IVF Process Step by Step: From Ovarian Stimulation to Embryo Transfer
Female Age Matters but Does Not Determine the Entire Plan
Female age strongly influences reproductive prognosis because age is associated with changes in oocyte and embryo chromosome status.
However, age alone is not sufficient to predict ovarian response or choose a stimulation dose.
Two women of the same age may have very different ovarian reserves and previous treatment histories.
Read also: IVF After Age 40 in Istanbul
Ovarian Reserve Helps Predict Response
AMH and antral follicle count are commonly used to estimate likely ovarian response.
The European Society of Human Reproduction and Embryology recommends either AMH or antral follicle count for predicting high or low ovarian response to stimulation.
However, ovarian reserve is not the same as oocyte quality.
It primarily helps estimate how the ovaries may respond to medication.
Why Do Stimulation Doses Differ?
A starting dose may be influenced by:
Ovarian reserve
Previous stimulation response
Antral follicle count
Expected high or low response
Safety considerations
Individual medical factors
The goal is not to use the highest dose possible.
It is to obtain an appropriate response while minimizing avoidable risk.
Does a Higher Dose Always Produce More Eggs?
No.
Medication cannot create a new ovarian reserve.
A very high dose does not guarantee substantially more oocytes in a patient with a limited follicular cohort.
Conversely, excessive medication in a high responder can increase ovarian hyperstimulation risk.
Previous IVF Cycles Can Be Extremely Informative
A previous cycle can show how the ovaries actually responded rather than only predicting response from testing.
Useful information includes:
Medication and doses
Follicle response
Oocyte number
Oocyte maturity
Fertilization
Embryo development
Freezing
Transfer
Pregnancy outcome
Complications
This information can help determine what should remain the same and what may need to change.
Read also: Why Does IVF Fail? Common Causes and What to Do Next
Semen Results Help Determine the Fertilization Strategy
IVF planning also includes the male partner.
Conventional IVF may be appropriate when semen parameters are suitable and there is no major fertilization concern.
ICSI may be more relevant when there is severe male-factor infertility, surgically retrieved sperm, or previous failed fertilization.
The American Society for Reproductive Medicine's 2026 committee opinion states that routine ICSI for patients without male-factor infertility or previous fertilization failure does not improve live-birth rates.
Read also: IVF vs ICSI: What Is the Difference and When Is Each Treatment Used?
Does a Low Egg Number Automatically Mean ICSI?
No.
Diminished ovarian reserve or a low expected oocyte yield alone does not establish that routine ICSI improves live-birth outcomes.
A previous fertilization problem or clear male factor changes the decision.
Can Medication Doses Change During the Cycle?
Yes.
A starting dose is not necessarily the dose used throughout stimulation.
Following monitoring, the physician may:
Continue the same dose
Increase or reduce medication
Add medication to prevent premature ovulation
Change the monitoring interval
Schedule final oocyte maturation
The plan therefore evolves according to actual ovarian response.
How Is Egg Retrieval Timing Chosen?
Egg retrieval is not fixed by calendar date before stimulation begins.
Follicular development, stimulation duration, overall response, and other clinical information are considered before the final trigger is scheduled.
Current European Society of Human Reproduction and Embryology guidance describes final oocyte-maturation timing as a multifactorial decision rather than one based on a single follicle measurement.
Why Can Fertilization Strategy Change Between Cycles?
If conventional IVF previously produced total or unexpectedly low fertilization, ICSI may be considered in a subsequent cycle.
If fertilization was normal, there may be no clear reason to change the method.
Read also: ICSI After Failed IVF: When Can It Be a Better Option?
When Is Fresh Embryo Transfer Planned?
Fresh transfer may be appropriate when the clinical circumstances are suitable.
The decision can consider:
Ovarian response
Ovarian hyperstimulation risk
Endometrial conditions
Embryo development
Relevant hormonal findings
Other medical considerations
Fresh transfer is therefore not automatically the correct endpoint for every stimulation cycle.

When Is a Freeze-All Strategy Used?
Embryos may instead be cryopreserved and transferred in a later cycle.
Possible reasons include:
High ovarian hyperstimulation risk
Preimplantation genetic testing
Endometrial or hormonal concerns
Need for uterine treatment
Another clinical reason to postpone transfer
Freeze-all should also not be used automatically for every patient.
The treatment strategy should have a clear indication.
Is Freeze-All Always Better?
No.
Neither fresh transfer nor freeze-all is universally superior for every patient.
The appropriate strategy depends on individual circumstances.
How Is the Number of Embryos to Transfer Decided?
The aim is not to transfer the maximum possible number of embryos.
Transferring more embryos increases multiple-pregnancy risk.
European Society of Human Reproduction and Embryology embryo-transfer guidance focuses on selecting an embryo-transfer strategy that balances the chance of pregnancy with the safety of the mother and baby.
Factors may include patient age, embryo stage, previous treatment history, embryo characteristics, and applicable clinical rules.
When Is PGT Included in the Plan?
Preimplantation genetic testing is not required in every IVF cycle.
It may be discussed depending on:
Specific inherited disease risk
Age and clinical history
Pregnancy-loss history
Embryo number and treatment circumstances
Different forms of PGT address different questions.
PGT for chromosomal-number screening is not the same as testing for a known monogenic condition.
Read also: IVF With PGT-A and PGT-M in Istanbul
How Does the Uterus Affect Planning?
Before embryo transfer, uterine findings may need to be reviewed.
Examples can include:
Endometrial polyps
Fibroids affecting the cavity
Adhesions
Hydrosalpinx
Relevant endometrial findings
This does not mean every IVF patient requires hysteroscopy.
Testing and procedures should be selected according to clinical indications.
Does Every Patient Need the Same Tests?
No.
There are core assessments that many patients need, but additional testing should answer specific clinical questions.
One patient may need further uterine assessment.
Another may need more detailed male-factor evaluation.
A couple with a known inherited condition may need specialized genetic counseling and testing.
More testing is not automatically better treatment.
How Does a Previous Failed Cycle Change the Plan?
Different previous outcomes point toward different questions.
| Previous Cycle Finding | What May Need Review? |
|---|---|
| Very low ovarian response | Stimulation strategy and expectations |
| Excessive response | Dose and OHSS prevention |
| Many oocytes but low maturity | Maturation and retrieval factors |
| Fertilization failure | Fertilization method and male factor |
| Embryo arrest | Oocyte, sperm, embryo, laboratory and age factors |
| Good embryos but no pregnancy | Transfer, uterine factors, age and broader context |
| Miscarriage | Age, pregnancy history, embryo and medical factors |
Repeating the same plan without reviewing what happened may miss useful information.
Why Can the Plan Change After Treatment Has Started?
Before stimulation, the physician works with predicted response.
During treatment, actual response becomes visible.
The team may discover:
Faster follicular development
Slower development
Higher or lower follicle number
Increased OHSS risk
A different embryo number than expected
Reasons to postpone fresh transfer
Updating the plan is therefore often part of individualized treatment rather than evidence that the original plan was wrong.
Why Shouldn't You Compare Your Dose With Another Patient?
A higher gonadotropin dose does not mean stronger or better treatment.
Dose differences can reflect:
Ovarian reserve
Follicle count
Previous response
Expected response
Safety considerations
Two patients of the same age may legitimately receive very different protocols.
Why Is There No Single “Best IVF Protocol”?
A protocol appropriate for a high responder may be unsuitable for a low responder.
A first IVF cycle in a younger patient may be planned differently from treatment in an older patient with several previous attempts.
Male-factor infertility, genetic disease, previous fertilization failure, and uterine findings can also change the plan.
Modern IVF therefore relies on selecting treatments for specific indications rather than adding every available intervention.
What Should You Understand Before Starting?
Ask the treatment team:
Why was this stimulation protocol selected?
What ovarian response is expected?
Why was this starting dose chosen?
Will conventional IVF or ICSI be used?
What is the initial embryo-transfer strategy?
Under what circumstances could the plan change?
Is PGT being considered, and why?
What did previous cycles teach us?
Is there a uterine issue that needs treatment first?
Initial Plan vs Final Plan
Before Treatment
The strategy is based on:
Age
Ovarian reserve
Medical history
Semen findings
Testing
Previous treatment
During Treatment
Further decisions incorporate:
Follicular development
Medication response
Oocyte number
Oocyte maturity
Fertilization
Embryo development
Endometrial conditions
Some important decisions therefore cannot be finalized until the cycle progresses.
IVF Planning Checklist
Before starting, make sure you understand:
What is the main infertility diagnosis?
Why is IVF being recommended?
What does ovarian reserve testing suggest?
What response is expected?
Why was this medication dose selected?
Will IVF or ICSI be used?
Is further male-factor evaluation needed?
Is fresh transfer or freeze-all initially planned?
What could cause a switch to freeze-all?
Is there a reason for PGT?
Does the uterus need further assessment?
What was learned from previous cycles?
What might cause the plan to change?
Conclusion
An IVF plan is not selected from a single standard template.
It combines:
age + ovarian reserve + expected response + male factors + previous treatment + fertilization strategy + embryo development + uterine findings + embryo-transfer planning
and is then modified according to the patient's actual response.
Two patients of the same age can therefore receive very different treatment plans and both plans may be appropriate.
The goal is not to use the highest medication dose, ICSI for every oocyte, PGT for every embryo, or freeze-all for every patient.
The goal is to use each intervention when there is a clear reason for it.
Fertiliv helps patients organize medical records and previous treatment information and coordinate review of an individualized IVF treatment plan.
Frequently Asked Questions: How Is an IVF Treatment Plan Chosen and Why Does It Differ Between Patients?
Why Do IVF Medication Doses Differ Between Patients?
Dose selection depends on ovarian reserve, expected response, previous treatment response, and other clinical factors.
Does Ovarian Reserve Measure Egg Quality?
No. It mainly helps predict ovarian response and potential oocyte yield, while age is particularly important for oocyte biology.
Is ICSI Better for Every IVF Patient?
No. It is useful when there is an appropriate indication and does not automatically improve live birth in every patient.
Why Can the Doctor Change the Plan During Stimulation?
Monitoring provides new information about actual ovarian response that may require dose, timing, or transfer-strategy changes.
Is Freeze-All Better Than Fresh Transfer?
Not universally. The appropriate approach depends on the patient's clinical circumstances.
Does Every Patient Need PGT?
No. Its use depends on the type of genetic question, age, history, and treatment circumstances.
Should I Use the Same Protocol as Someone With Similar Age?
No. Ovarian reserve and treatment response can differ substantially even between patients of the same age.
Can a Previous IVF Cycle Help Plan the Next One?
Yes. Previous ovarian response, oocyte maturity, fertilization, embryo development, and outcomes can provide valuable information.
